Expired Annual Drug Patent for NOCDURNA
Nocdurna is a drug marketed by Ferring Pharms Inc and included in one NDA. It is available from a single supplier. There are ten patents protecting this drug.
Drug patent litigation for NOCDURNA.
This drug has one hundred patent family members in thirty-four countries.
The generic ingredient in NOCDURNA is desmopressin acetate. One registered supplier for this compound. Additional details are available on the desmopressin acetate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
Copyright © DrugPatentWatch. Originally published on new patent expiry for Ferring Pharms drug NOCDURNA